CIK: 1304395 - Address: C/O Phio Pharmaceuticals Corp., 257 Simarano Drive, Suite 101, Marlborough, MA 01752
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret113-3-5-9-301-49-16
P%wins3300067017

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/27/24 16:42
2/26/24
PHIOPhio Pharmaceuticals Corp.DEHealthDrugPharmaceutical PreparationsBitterman Robert JMADOP,CEOP20.9100031519D
12/15/22 17:00
12/14/22
PHIOPhio Pharmaceuticals Corp.DEHealthDrugPharmaceutical PreparationsBitterman Robert JMADOInterim P10.390002375D
12/8/22 16:30
12/7/22
PHIOPhio Pharmaceuticals Corp.DEHealthDrugPharmaceutical PreparationsBitterman Robert JMADOInterim P10.390002373D
12/6/22 16:30
12/5/22
PHIOPhio Pharmaceuticals Corp.DEHealthDrugPharmaceutical PreparationsBitterman Robert JMADOInterim P10.430002371D
11/29/22 16:30
11/25/22
PHIOPhio Pharmaceuticals Corp.DEHealthDrugPharmaceutical PreparationsBitterman Robert JMADOInterim P.m10.418403469D
11/16/22 17:06
11/16/22
PHIOPhio Pharmaceuticals Corp.DEHealthDrugPharmaceutical PreparationsBitterman Robert JMADOInterim P21,750.000New0D
1/23/15 08:50
1/22/15
RXIIRxi Pharmaceuticals CorpDEHealthDrugPharmaceutical PreparationsBitterman Robert JMADP61.20053337D-48-73-51-43-40-24-21-2-3-5-8-45-61-75
8/27/13 09:36
8/26/13
RXIIRxi Pharmaceuticals CorpDEHealthDrugPharmaceutical PreparationsBitterman Robert JMADP23.9001502D0-21-35-21-323-6-8-10-2154-35
8/5/13 16:43
8/5/13
RXIIRxi Pharmaceuticals CorpDEHealthDrugPharmaceutical PreparationsBitterman Robert JMADP44.0801New1D1584-34-31-19-16-21-2-10-2311-37

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact